PL107847B1 - Method of producing new alpha-omega diguanidinoalksposob wytwarzania nowych alfa,omega dwuguanidynoalkanow anes - Google Patents

Method of producing new alpha-omega diguanidinoalksposob wytwarzania nowych alfa,omega dwuguanidynoalkanow anes Download PDF

Info

Publication number
PL107847B1
PL107847B1 PL1977199908A PL19990877A PL107847B1 PL 107847 B1 PL107847 B1 PL 107847B1 PL 1977199908 A PL1977199908 A PL 1977199908A PL 19990877 A PL19990877 A PL 19990877A PL 107847 B1 PL107847 B1 PL 107847B1
Authority
PL
Poland
Prior art keywords
formula
omega
histamine
producing new
new alpha
Prior art date
Application number
PL1977199908A
Other languages
English (en)
Polish (pl)
Other versions
PL199908A1 (pl
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of PL199908A1 publication Critical patent/PL199908A1/xx
Publication of PL107847B1 publication Critical patent/PL107847B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL1977199908A 1976-07-28 1977-07-28 Method of producing new alpha-omega diguanidinoalksposob wytwarzania nowych alfa,omega dwuguanidynoalkanow anes PL107847B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3139176 1976-07-28

Publications (2)

Publication Number Publication Date
PL199908A1 PL199908A1 (pl) 1978-11-20
PL107847B1 true PL107847B1 (pl) 1980-03-31

Family

ID=10322405

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1977199908A PL107847B1 (pl) 1976-07-28 1977-07-28 Method of producing new alpha-omega diguanidinoalksposob wytwarzania nowych alfa,omega dwuguanidynoalkanow anes

Country Status (15)

Country Link
JP (1) JPS5315370A (enExample)
AU (1) AU2734677A (enExample)
BE (1) BE857218A (enExample)
CA (1) CA1070315A (enExample)
DE (1) DE2733953A1 (enExample)
DK (1) DK331877A (enExample)
ES (1) ES461100A2 (enExample)
FI (1) FI772293A7 (enExample)
FR (1) FR2359840A1 (enExample)
IL (1) IL52544A0 (enExample)
LU (1) LU77845A1 (enExample)
NL (1) NL7708375A (enExample)
NO (1) NO772668L (enExample)
PL (1) PL107847B1 (enExample)
ZA (1) ZA774552B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309435A (en) * 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
FR2446829A1 (fr) 1978-11-16 1980-08-14 Glaxo Group Ltd Derives de polymethylene disubstitues en alpha, omega, procede pour leur preparation et compositions pharmaceutiques les contenant
JPS57102852A (en) * 1980-12-19 1982-06-26 Shionogi & Co Ltd Dicarboxylic acid diamide
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Also Published As

Publication number Publication date
FI772293A7 (enExample) 1978-01-29
LU77845A1 (enExample) 1977-10-25
AU2734677A (en) 1979-02-01
ES461100A2 (es) 1978-12-01
BE857218A (fr) 1978-01-27
NO772668L (no) 1978-01-31
DK331877A (da) 1978-01-29
DE2733953A1 (de) 1978-02-02
JPS5315370A (en) 1978-02-13
PL199908A1 (pl) 1978-11-20
IL52544A0 (en) 1977-10-31
FR2359840A1 (fr) 1978-02-24
CA1070315A (en) 1980-01-22
NL7708375A (nl) 1978-01-31
ZA774552B (en) 1978-06-28

Similar Documents

Publication Publication Date Title
US4347250A (en) Pyridyl alkylthiourea and alkylamino-nitroethylene
US3897444A (en) Pharmacologically active compounds
CA1099268A (en) Aminoalkyl-furanylalkyl-urea derivatives
US4034101A (en) N-Oxy and N-amino guanidines
DE2643670C2 (de) 5-Benzyl-4-pyrimidon-Derivate, ihre Salze mit Säuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4301165A (en) Pharmacologically active compounds
US4013659A (en) Certain n,n'-disubstituted guanidine compounds and their use
US4265896A (en) Amidinosulphonic acid derivatives
CA1075702A (en) Process for the preparation of substituted guanidine compounds
US4282234A (en) Certain heterocyclic-methylthioalkyl guanidine derivatives
PL107847B1 (pl) Method of producing new alpha-omega diguanidinoalksposob wytwarzania nowych alfa,omega dwuguanidynoalkanow anes
US4118496A (en) Heterocyclic-methylthioalkyl-amidines
US4285952A (en) Pyridyl, thiazolyl and isothiazolyl alkyl bisamidines
US4169855A (en) N'-derivatives of n-(2-mercapto-ethyl)-2-nitro-1,1-ethenediamine
US3932427A (en) Pyridyl substituted aminoalkyl-thioureas and ureas
NO772669L (no) Fremgangsm}te for fremstilling av farmakologisk aktive forbindelser
US4374839A (en) Pharmacologically active 1,3-bis[(2-heterocyclyl-methyl-thio)ethyl)ethyl)guanidino]alkane derivatives
US4166856A (en) Thiazole and isothiazole derivative as blockers of histamine H2 -receptors
US4133886A (en) Guanidino, thioureido, isothioureido and nitrovinylamino derivatives of pyridine
CY1276A (en) N,n'-bis(n-cyano-n'-alkynyl)methanimidamidyl cystamines
US4018928A (en) Pyridyl substituted aminoalkyl-thioureas and ureas
US4093729A (en) N-Oxy and N-amino guanidines
PL130912B1 (en) Process for preparing novel,water-soluble salts of 1,1-dioxide of n-/2-pyridyl/-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carbonamide with lysine or arginine
US4192879A (en) Imidazolyl alkylamino nitroethylene compounds
US4160030A (en) N-oxy and N-amino guanidines